Search clinical trials for: HER2-low Breast Cancer
Total 88835 results
-
AstraZenecaDaiichi SankyoRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerCanada
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerChina
-
RemeGen Co., Ltd.Not yet recruiting
-
MedSIRDaiichi SankyoNot yet recruitingBreast Cancer | Metastatic Breast Cancer
-
DualityBio Inc.BioNTech SERecruitingMetastatic Breast CancerUnited States, China, France, Australia
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
AstraZenecaRecruiting
-
AstraZenecaRecruitingBreast CancerItaly, Spain, United Kingdom, Canada, United States, Israel, Switzerland, Brazil, Austria
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingBreast Cancer | HER2-low Breast CancerChina
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
Daiichi SankyoCompletedHER2-negative Breast Cancer | HER2-low Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...Completed
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer | Neoadjuvant Therapy | Hormone Receptor-positive Breast Cancer | HER2-low-expressing Breast CancerChina
-
BayerCompletedCancers With HER2 ExpressionUnited States, United Kingdom
-
Mersin UniversityNot yet recruitingPatients With Breast CancerTurkey
-
Institut CurieNot yet recruitingMetastatic Breast CancerFrance
-
ProDa BioTech, LLCEmory University; Georgia State UniversityNot yet recruitingTriple Negative Breast CancerUnited States
-
Candiolo Cancer Institute - IRCCSRecruitingSexual Dysfunction | Breast Cancer Female | Premenopausal Breast CancerItaly
-
Assiut UniversityNot yet recruiting
-
Roswell Park Cancer InstituteRecruitingMalignant Solid Neoplasm | Breast Carcinoma | Kidney Carcinoma | Malignant Thoracic NeoplasmUnited States
-
Min Yan, MDBeijing Biostar Pharmaceuticals Co., Ltd.RecruitingBreast Cancer RecurrentChina
-
Ningbo No. 1 HospitalRecruitingPrimary Central Nervous System LymphomaChina
-
University of TorontoCanadian Institutes of Health Research (CIHR)Not yet recruitingSedentary Behavior | Metabolic Disturbance | Breast Cancer FemaleCanada
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Amsterdam UMC, location VUmcBorstkanker Onderzoek Groep; Comprehensive Cancer Centre The Netherlands; Dutch...RecruitingBreast Cancer | Hyperthermia | Locoregional Recurrence | Re-irradiationNetherlands
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Not yet recruiting
-
Swiss Group for Clinical Cancer ResearchNot yet recruiting
-
Zumutor Biologics Inc.RecruitingColorectal Cancer | Esophageal Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreas Adenocarcinoma | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Biliary Tract Cancer | High Grade Ovarian Serous AdenocarcinomaUnited States
-
Mayo ClinicNot yet recruitingHER2-Negative Breast Carcinoma | Estrogen Receptor-Positive Breast CarcinomaUnited States
-
UNICANCERNatera, Inc.Not yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer
-
Pontificia Universidad Catolica de ChileNot yet recruiting
-
Fudan UniversityRecruitingAdvanced Breast Cancer | HR+/HER2- Breast CancerChina
-
Changchun GeneScience Pharmaceutical Co., Ltd.Not yet recruiting
-
PfizerNot yet recruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Carcinoma, Pancreatic Ductal
-
BioNTech SENot yet recruitingTriple Negative Breast Cancer | Locally Advanced Breast Cancer
-
Shandong UniversityChinese PLA General HospitalNot yet recruitingTriple Negative Breast Cancer | Sensitivity | Neoadjuvant Immunotherapy
-
Sichuan Kelun Pharmaceutical Research Institute...Recruiting
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruiting
-
Fundacio Clinic BarcelonaUniversity of Padova; Sheba Medical Center; Istituto Oncologico Veneto IRCCS; University... and other collaboratorsNot yet recruitingHER2-positive Breast Cancer | Early-stage Breast Cancer
-
KaliVir ImmunotherapeuticsNot yet recruitingKidney Cancer | Renal Cell Carcinoma | Cervical Cancer | Mesothelioma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Solid Tumor, Adult | Microsatellite Stable Colorectal Cancer | Melanoma Stage IV | Merkel Cell Carcinoma of Skin
-
Breast Cancer Trials, Australia and New ZealandNot yet recruitingBreast Cancer | Breast Cancer Female
-
University of Texas Southwestern Medical CenterNot yet recruiting
-
Institut de cancérologie Strasbourg EuropeNot yet recruiting
-
William Beaumont HospitalsRecruiting
-
University of Illinois at ChicagoRecruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI)Not yet recruitingBreast Cancer FemaleUnited States
-
Astellas Pharma Global Development, Inc.Not yet recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingBreast Cancer | Triple Negative Breast Cancer | Chemotherapy Effect | Risk Factors | Recurrence, Local NeoplasmItaly